Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$1.03M Buy
19,376
+12,960
+202% +$725K 0.53% 62
2014
Q3
$369K Hold
6,416
0.18% 121
2014
Q2
$429K Sell
6,416
-860
-12% -$58.2K 0.21% 116
2014
Q1
$486K Sell
7,276
-3,120
-30% -$211K 0.24% 109
2013
Q4
$694K Sell
10,396
-9,200
-47% -$597K 0.33% 88
2013
Q3
$1.23M Sell
19,596
-2,060
-10% -$133K 0.68% 42
2013
Q2
$1.35M Buy
+21,656
New +$1.37M 0.79% 36

Other funds holding GSK

Dominick & Dominick's GSK Position: Q4 2014 in Review

Dominick & Dominick increased its GSK (GSK) stake by 202% in Q4 2014, buying an estimated $725K and bringing the position to 19,376 shares worth $1.03M. The position accounts for 0.53% of the portfolio, ranked #62.

Dominick & Dominick first reported a position in GSK in Q2 2013 and has held it in 7 quarters since. The position peaked at $1.35M in Q2 2013. 728 funds tracked by Wall St. Rank hold GSK as of Q4 2014.

  • Dominick & Dominick held 19,376 shares of GSK worth $1.03M as of Q4 2014.
  • Dominick & Dominick bought 12,960 GSK shares in Q4 2014, an estimated $725K.
  • GSK made up 0.53% of Dominick & Dominick's portfolio in Q4 2014, its #62 holding.
  • Dominick & Dominick first reported a position in GSK in Q2 2013 and has held it in 7 quarters since.
  • Dominick & Dominick's GSK position peaked at $1.35M in Q2 2013.
  • 728 funds tracked by Wall St. Rank held GSK as of Q4 2014.

Based on Dominick & Dominick's 13F filing for Q4 2014, filed 22 Jan 2015.